John R. Jacob

441 total citations
21 papers, 321 citations indexed

About

John R. Jacob is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, John R. Jacob has authored 21 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Genetics. Recurrent topics in John R. Jacob's work include Glioma Diagnosis and Treatment (5 papers), Colorectal Cancer Screening and Detection (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). John R. Jacob is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Colorectal Cancer Screening and Detection (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). John R. Jacob collaborates with scholars based in United Kingdom, United States and Denmark. John R. Jacob's co-authors include Kamalakannan Palanichamy, Arnab Chakravarti, Disha Patel, Krishnan Thirumoorthy, Suman Kanji, Peter J. Goadsby, John S. Duncan, James Briscoe, Marie-Catherine Tiveron and Jean‐François Brunet and has published in prestigious journals such as Development, Neurology and Clinical Cancer Research.

In The Last Decade

John R. Jacob

18 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John R. Jacob United Kingdom 10 199 56 45 40 39 21 321
Lauren Bryan United States 12 371 1.9× 98 1.8× 46 1.0× 21 0.5× 32 0.8× 12 534
E. Edwards United States 7 265 1.3× 68 1.2× 104 2.3× 28 0.7× 60 1.5× 8 460
Mariane da Cunha Jaeger Brazil 12 239 1.2× 44 0.8× 28 0.6× 20 0.5× 105 2.7× 34 429
Samuel O. Lawn Canada 6 198 1.0× 45 0.8× 42 0.9× 15 0.4× 81 2.1× 6 312
J. M. Kros Netherlands 8 229 1.2× 55 1.0× 26 0.6× 54 1.4× 46 1.2× 11 486
Chen Khuan Wong United States 10 278 1.4× 94 1.7× 97 2.2× 40 1.0× 43 1.1× 11 457
Yoneko Hayase Japan 11 167 0.8× 43 0.8× 48 1.1× 62 1.6× 156 4.0× 22 408
Yoko Shinoda Japan 11 276 1.4× 34 0.6× 10 0.2× 23 0.6× 50 1.3× 18 434
Junya Nakade Japan 5 147 0.7× 51 0.9× 96 2.1× 19 0.5× 99 2.5× 9 329
Mariangela Mastrapasqua Italy 11 154 0.8× 24 0.4× 17 0.4× 19 0.5× 33 0.8× 19 432

Countries citing papers authored by John R. Jacob

Since Specialization
Citations

This map shows the geographic impact of John R. Jacob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Jacob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Jacob more than expected).

Fields of papers citing papers by John R. Jacob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Jacob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Jacob. The network helps show where John R. Jacob may publish in the future.

Co-authorship network of co-authors of John R. Jacob

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Jacob. A scholar is included among the top collaborators of John R. Jacob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Jacob. John R. Jacob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Thomas, Simon Anderson, Angus Watson, et al.. (2025). Factors predicting conversion from colon capsule endoscopy to conventional optical endoscopy—findings from the CESCAIL study. BMC Gastroenterology. 25(1). 363–363.
2.
Beintaris, Iosif, et al.. (2025). Calcium electroporation for palliation of colorectal cancer. Endoscopy. 57. 1 indexed citations
3.
Lee, Thomas, Simon Anderson, Angus Watson, et al.. (2025). O14 Is AI the game-changer for polyp detection in colon capsule endoscopy? Insights from the CESCAIL study. Oral Presentations. A9–A10.
5.
Jacob, John R., Kamalakannan Palanichamy, & Arnab Chakravarti. (2024). Antipsychotics possess anti-glioblastoma activity by disrupting lysosomal function and inhibiting oncogenic signaling by stabilizing PTEN. Cell Death and Disease. 15(6). 414–414. 8 indexed citations
6.
Jacob, John R., et al.. (2023). miRNA-194-3p represses NF-κB in gliomas to attenuate iPSC genes and proneural to mesenchymal transition. iScience. 27(1). 108650–108650. 5 indexed citations
7.
Wolfe, Adam R., Ryan Robb, Laith Abushahin, et al.. (2020). Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic Cancer. Clinical Cancer Research. 27(2). 554–565. 8 indexed citations
8.
Palanichamy, Kamalakannan, et al.. (2018). Cells isolated from residual intracranial tumors after treatment express iPSC genes and possess neural lineage differentiation plasticity. EBioMedicine. 36. 281–292. 9 indexed citations
9.
Palanichamy, Kamalakannan, et al.. (2017). Lack of Constitutively Active DNA Repair Sensitizes Glioblastomas to Akt Inhibition and Induces Synthetic Lethality with Radiation Treatment in a p53-Dependent Manner. Molecular Cancer Therapeutics. 17(2). 336–346. 9 indexed citations
10.
Palanichamy, Kamalakannan, Suman Kanji, Krishnan Thirumoorthy, et al.. (2016). NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability. Clinical Cancer Research. 23(9). 2325–2334. 64 indexed citations
11.
Palanichamy, Kamalakannan, Krishnan Thirumoorthy, Suman Kanji, et al.. (2016). Methionine and Kynurenine Activate Oncogenic Kinases in Glioblastoma, and Methionine Deprivation Compromises Proliferation. Clinical Cancer Research. 22(14). 3513–3523. 48 indexed citations
12.
Palanichamy, Kamalakannan, et al.. (2015). Clinically Relevant Brain Tumor Model and Device Development for Experimental Therapeutics. 4(1). 5 indexed citations
13.
Jacob, John R., Vanessa Ribes, Steven Moore, et al.. (2013). Valproic Acid silencing ofascl1b/ascl1results in the failure of serotonergic differentiation in a zebrafish model of Fetal Valproate Syndrome. Disease Models & Mechanisms. 7(1). 107–17. 31 indexed citations
14.
Chargari, Cyrus, et al.. (2011). Granulocytic Sarcoma in a Nonleukemic Patient: Place of Radiotherapy and Systemic Therapies. Case Reports in Medicine. 2011. 1–4. 2 indexed citations
15.
Jacob, John R., Diogo S. Castro, Patrick Pla, et al.. (2009). Insm1 (IA-1) is an essential component of the regulatory network that specifies monoaminergic neuronal phenotypes in the vertebrate hindbrain. Development. 136(14). 2477–2485. 43 indexed citations
16.
Jacob, John R.. (2003). The clinicopathological spectrum of Rosenthal fibre encephalopathy and Alexander's disease: a case report and review of the literature. Journal of Neurology Neurosurgery & Psychiatry. 74(6). 807–810. 22 indexed citations
17.
Jacob, John R., Marie-Catherine Tiveron, Jean‐François Brunet, & Sarah Guthrie. (2000). Role of the Target in the Pathfinding of Facial Visceral Motor Axons. Molecular and Cellular Neuroscience. 16(1). 14–26. 23 indexed citations
18.
Jacob, John R., Tamás Révész, Maria Thom, & Martin N. Rossor. (1999). A Case of Sporadic Pick Disease With Onset at 27 Years. Archives of Neurology. 56(10). 1289–1289. 9 indexed citations
19.
Jacob, John R., Peter J. Goadsby, & John S. Duncan. (1996). Use of sumatriptan in post-ictal migraine headache. Neurology. 47(4). 1104–1104. 30 indexed citations
20.
PANTELOURIS, E.M. & John R. Jacob. (1958). Nuclear chimaeras in the newt. Cellular and Molecular Life Sciences. 14(3). 99–99. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026